Document is current

Any future updates will be listed below

Topical Sirolimus 0.2% Gel for the Management of Tuberous Sclerosis Complex-Related Cutaneous Manifestations: An Interim Analysis of Postmarketing Surveillance in Japan

Crossref DOI link: https://doi.org/10.1007/s13555-023-00914-2

Published Online: 2023-03-11

Published Print: 2023-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark